Annually, more than 9 million single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) studies are performed in North American (1, 2). The unexpected shut down of the Canadian Chalk River nuclear reactor in May 2009 resulted in a worldwide shortage in technetium-99m (Tc-99m) based radiotracers(3). In response, many centres substituted thallium-201 (Tl-201) for Tc-99m based radiotracers to ensure clinical MPI needs were met (3-6).
Although Tl-201was historically a SPECT MPI radiotracer, Tc-99m based myocardial perfusion radiotracers were adopted into clinical practice because of better image quality, lower susceptibility to attenuation artifacts, shorter half-life and lower patient radiation exposure (6, 7).
At the time, Tl-201 was a reasonable alternative to Tc-99m, but some have questioned if this strategy is an appropriate response for future shortages. Since future shortages of Tc-99m are anticipated, the medical community needs to understand the implications of Tl-201 use (3, 7).
Given the potentially inferior imaging characteristics of Tl-201, the impact of using Tl-201 as an alternative may have significant impact upon healthcare and resource utilization. Therefore we sought to determine the potential impact of Tl-201 upon downstream resource utilization, radiation exposure and cost.
Methods
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Patients were excluded from analysis if they were participating in research that mandated downstream testing with PET (29 patients), CCTA (3 patients) , ICA (0 patients), or stress ECHO (0 patients), or were referred for SPECT-MPI imaging in May 2009 or August 2010 when supplies of technetium were still available but limited.
Patients were divided into three groups according to the timing of SPECT in relation to the Tc-99m shortage: 1) prior to the Tc-99m shortage (PRE_Tc-99m), 2) during the Tc99m
shortage when Tl-201 was used (DURING_Tl-201) and 3) after the resolution of the Tc-99m
shortage (POST_Tc-99m). This study was approved by the University of Ottawa Human
Research Ethics Board.
Clinical characteristics
SPECT patients had a clinical history recorded at the time of their SPECT study to assess symptoms, the presence of risk factors and the occurrence of previous coronary revascularization. The Morise score (based upon pre-test probability and cardiac risk factors) was calculated for all groups (8, 9).
SPECT imaging
Rest/stress Tc-99m (Myoview, GE Healthcare) and stress/redistribution Tl-201 (Thallous chloride, Lantheus Medical Imaging) SPECT MPI were performed as per clinical routine and following the American Society of Nuclear Cardiology guidelines (10) . In brief, patients underwent a 1-day (87.8% of patients) or 2-day rest/stress Tc-99m, or a stress/redistribution Tl-201 SPECT (symptom-limited treadmill exercise or pharmacological stress) (11) . All images were acquired on the same dual headed cameras using low energy high resolution collimators with a 15% energy window centered on the 140keV photopeak for Tc-99m or 30% energy window centered on the 70keV peak and 15% centered on the 167keV energy peak for Tl-201 (10) . ECG-gated SPECT data were acquired (25sec/projection x 60 projections over 180 0 ) and reconstructed with filtered back projection using a 64x 64 matrix. SPECT images were review by expert observers with 10 years experience in reading Tl-201 and Tc-99m studies using a standardized reporting template (12) (13) (14) (15) .
Patients were categorized as normal (no obstructive CAD) or abnormal (evidence of obstructive CAD (ischemia or scar)) based upon assessment of MPI results (12) . Procedures interpreted as inconclusive due to a failure to achieve 85% maximum age predicted heart rate with exercise stress were labeled as equivocal for the purpose of the study, images that were not interpretable for technical failure reasons were also labeled as equivocal. To better understand the reasons for downstream resource utilization, SPECT MPI for those patients referred for further testing was evaluated using a 17-segment model and 5 point scale (0 = normal, 1 = mild, 2 = moderate, 3 = severe and 4 = absent tracer uptake), to calculate summed stress and rest scores (12) .
Patient follow-up
To provide contemporary downstream investigation data that was relative to the index SPECT test, patients' records at the Ottawa Heart Institute were analyzed for 6 months after the index SPECT MPI. Rates and results were thus determined for downstream resource utilization of ICA, CCTA, PET, stress ECHO and coronary revascularization. Individual radiation dose estimates were captured for each index SPECT and downstream test.
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Costs
The adjusted odds ratio (OR) with 95% CI were reported. The goodness-of-fit of the models was assessed using the Hosmer-Lemeshow test. The models with and without propensity score adjustment were evaluated using a likelihood ratio test. 
Results

A
Patient characteristics
Though most clinical variables were similar between the PRE_Tc-99m and POST_TC-99m groups, symptoms (chest pain, dyspnea) were more frequently recorded in POST_TC-99m in comparison to PRE_Tc-99m (58.4% versus 62.5% p=0.01). The DURING_Tl-201 and ALL_Tc-99m cohorts had similar patient characteristics for most variables. The increase in downstream testing associated with thallium imaging persisted when comparisons were made by adjustments with the propensity scores in the logistic models (Table   2 ). Overall the model, adjusted for propensity scores, did not show better fit to the data m were high ri i i isk sk sk s sk s s n T e t e ng g g g g f f f f followi wi wi wing ng ng ng n S S S S SPE PE PE PE PECT CT CT CT CT Tc-9 -9 -9 9 -99m 9m 9m 9m 9m, DU DU DU DU DURI R RI R R NG NG NG NG NG T _T T T Tl-l l l l 20 0 0 0 01 1 1 1 1 pa pa pa pa pati ti ti ti tie e e ent nt nt nt n s s s s s we we we we were re re re re a a a alm lm lm lm lmos os ost t t t tw tw tw tw twic ic ic ic ice e e e as as as as l l l l lik k ik k ke suggesting that the pre-selection bias was minimal in the current study. The propensity score was only identified as having significant impact to the ICA testing between groups. The HosmerLemeshow tests were large (p=NS) indicating that there was not a 'lack of fit' of these models.
The most frequent downstream procedure was ICA, with CCTA being the second most requested downstream test (Table 2) .
Downstream Cardiac Catheterization
ICA was performed in 13.3% of the DURING_Tl-201 patients which was almost double of those performed in the Tc-99m groups (adjusted OR (95%CI): 1.93 (1.64, 2.26), p< 0.001) ( Table 2 ). The model adjusted for propensity scores had a better fit to the data (likelihood ratio test p<0.001) and the propensity score has a significant impact to the ICA testing between groups (p=0.007).
Of the 394 patients DURING_Tl-201 referred for ICA, 72.6% had obstructive coronary disease (stenosis 50%) with 210 (53.3%) requiring revascularization. In comparison 324 individuals were catheterized from ALL_Tc-99m in whom 75.6% had obstructive disease and 191 were revascularized (59.0%) (p=0.132) ( Table 3) .
Downstream Coronary CT angiography
CCTA was not performed in patients with significant ischemia ( 
Accuracy in Patients Referred for Downstream Testing
Downstream tests (ICA, CCTA) were more often performed on normal SPECT studies following ALL_Tc-99m rather than DURING_Tl-201 (Table 3 ). The rate of true positive SPECT studies was similar between the DURING_Tl-201 and ALL_Tc-99m patients (54.3% and 59.3%, respectively; p=0.712). False positive results were more common in the DURING_Tl-201 than the ALL_Tc-99m patients (30.3% versus 16.4%, respectively; p<0.001). Excluding patients with true positive results (i.e. the patient population in whom downstream testing may be justified) more procedures were still performed in the DURING_Tl-201 group than the ALL_Tc-99m group (9.8% versus 5.4%, respectively; p<0.001) ( Table 2) .
Costs Associated with Downstream Testing
Cost analyses were calculated examining the expense incurred from the downstream tests.
Inclusion of all downstream procedures following the index SPECT study resulted in an increase groups (0.2% % % % % % % fo f f f f f f o the he e e e e e p p p p p p pro ro ro ro ro ro rope pe pe pe pe pe pens ns ns ns ns ns nsit it it it it it ity a t 
C s ac ac ac a a t t t t t to the he he he s s s s str t tr t t es es es es ess s s s s EC EC EC EC ECHO HO HO HO HOs s s s s te t t t st st
ts R R R R Ref ef ef ef efer er er er erre re re ed d d d d fo fo fo fo for r r r r Do Do Do Do Down wn wn wn wnst t t t tre re re re ream am am am am T T T T Tes es es es sti ti ti ti ting ng ng ng ng
C C CA A A, C C CCT CT CT C A) A) A) w w wer er ere e e mo mo more re re o o of f fte te ten n n pe pe pe p p rf rf rfor or or r rme me med d d on on on n n nor or orma ma mal l l SP SP SPEC EC ECT T T s s s f f f f f f in 
t t tai ai ai ai aine ne n ne n d d d d d wi wi w w w th th th th th t t t the he he h h e e e exc xc xc xc xclu lu lu lu lusi i i i ion on on on on o o o o of f f f pa pa pa pa pati ti ti ti tien en en en ents ts ts ts ts w w w w wit it it it ith h h h h tr tr tr t tru ue u p p p p pos os os os osit i it it itiv iv iv iv i
Temporal Changes in Downstream Testing after Tc-99m SPECT
There appeared to be a temporal change in downstream resource utilization when comparing the PRE_Tc-99m and POST_Tc-99m groups with a 3% absolute reduction in downstream resource utilization (13.3% of PRE_Tc-99m group versus 9.7% of POST_Tc-99m group, p<0.001) ( Table   3 ). 
Contributors to the Increased Resource Utilization with Tl-201
DURING_Tl-201 patients, although not matched with ALL_Tc-99m patients, had similar demographic characteristics, pre-test probability for coronary disease and similar frequencies of reported symptoms. Referral rates in the current study were within the ranges observed in other
North American studies and similar to those seen in multicenter trials (11, (27) (28) (29) .
Higher SDS were noted in DURING_Tl-201 patients referred for downstream testing in comparison to ALL_Tc99m. This finding may reflect differences in the radiotracers properties, with more severe stress defects observed with Tl-201 (7, 30). These inequalities may give rise to greater differences between rest and stress uptake and thus larger SDS with Tl-201 (7, 30).
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The increased false-positive results and decreased specificity from Tl-201 imaging likely reflect differences in the quality of images obtained with this radiotracer (7) and may require consideration when contemplating Tl-201 as an option for the next Tc-99m shortage.
Alternatives to Tc-99m
The Chalk River medical nuclear reactor, which is responsible for 40% of the world's supply of incurring an increase in resource utilization (11, 16) . Whether this would hold true for all patient groups especially those with prior revascularization would require further evaluation. If the capacity of all these alternative modalities could be increased to accommodate > 9 million SPECT MPIs performed annually, they would provide useful alternatives to alleviate the demands upon Tc-99m in future shortages.
Temporal Changes in Downstream Resource Utilization following Tc-99m SPECT
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Limitations
This was a single centre retrospective analysis of a prospectively collected SPECT registry.
Although not a randomized study, pre-selection bias of patients was adjusted for using propensity score stratification. Propensity score adjustment did not predict downstream testing and suggests for the measured cardiovascular risks there was no significant pre-selection bias.
Though a single centre study, our institution is a regional centre where dedicated cardiac catheterization, cardiac CT and cardiac PET facilities are centralized. Therefore if patients were referred for these tests following their SPECT it is highly likely that these procedures would only have been performed in our centre. Nevertheless despite these factors and meticulous collection of data it is possible that incomplete patient follow may have occurred.
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Patient records were analyzed for the 6 months following their index SPECT to ensure downstream resource utilization was contemporary with the SPECT results. Our rates of downstream testing referral rates are consistent with published data (27) (28) (29) 47 ). Clinical outcomes other than cardiac revascularization could not be collected, therefore outcomes of patients who did not receive downstream testing is unknown and overall cost-effectiveness per se could not be determined. Long-term follow-up for major adverse cardiac events was not performed and therefore the impact of the differences observed in Tl-201 and Tc-99m are unknown.
As this was an observational study, coronary angiography was not performed on all patients undergoing SPECT. Therefore accuracy comparisons between technetium and thallium imaging are limited to the biased population who underwent subsequent testing and/or coronary angiography. Examining the potential accuracy of SPECT in patients referred for additional testing, there was a trend towards improved accuracy with Tc-99m (p=0.098) however this result should be interpreted with caution.
Similarly physiological assessment with coronary flow wire technique was not performed on all lesions suspected to be obstructive thus obstructive coronary disease was limited to anatomical findings and not a physiological assessment at cardiac catheterization. Furthermore no calculation has been provided to account for auxiliary costs associated with downstream tests that would have contributed to the financial burden.
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